- Published at
- by gurufocus.com
positive
positive
Heidelberg Pharma AG (XTER:HPHA) Full Year 2024 Earnings Call Highlights: Navigating Financial Challenges with Strategic Partnerships
Sales Revenue and Other Income: EUR12 million in fiscal year 2024, down from EUR16.8 million in 2023.Sales Revenue: EUR6.9 million in 2024, compared to EUR9.9